Directory
>
Steven Ringel
Steven Ringel
Advisor | Tempus AI
Chicago, Illinois, United States
Steven Ringel
Summary
Steven Ringel is a seasoned professional in the commercial physical research industry, currently serving as the General Manager at Tempus, where he leads innovative initiatives in clinical trials. With a strong background in leadership development and consulting, he is passionate about empowering patients with rare diseases through access to experimental therapies. Steven's career spans various roles in biopharma, including significant positions at Sema4, where he advanced healthcare strategies and partnerships. His experience in both corporate and startup environments equips him with a unique perspective on the healthcare landscape. A graduate of Vanderbilt University, Steven combines his expertise in data analysis and public speaking to advocate for change in patient care. He is also fluent in conversational French, enhancing his ability to connect in diverse environments. Steven's commitment to transforming treatment access showcases his dedication to making a meaningful impact in the healthcare sector.
Steven Ringel
Work Experience
Advisor at
Nurture Genomics
July 2023 - Present
Vice President & General Manager, TIME (Clinical Trials) at
Tempus AI
January 2023 - Present
Vice President & General Manager, Biopharma at
Sema4
May 2022 - January 2023
Vice President & General Manager, Rare Disease at
Sema4
September 2021 - May 2022
Senior Director Corporate Development at
Sema4
March 2021 - November 2021
Director Of Business Development at
Sema4
February 2020 - March 2021
Director of Strategy at
Sema4
March 2018 - February 2020
Senior Associate Consultant at
Bain & Company
August 2015 - March 2018
Market Development Associate at
Illumina
October 2017 - March 2018
Steven Ringel
Education
Vanderbilt University, Bachelor Of Arts (B.A.), Cum Laude
January 2011 - January 2015
New Trier High School
January 2007 - January 2011
Frequently Asked Questions about Steven Ringel
What is Steven Ringel email address?
Steven Ringel's primary email address is *************@tempus.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Steven Ringel work for?
Steven Ringel is a Advisor at Tempus AI, a company specializing in Prepackaged software.
Where Steven Ringel graduated from?
Steven Ringel holds a degree in Communication Studies from Vanderbilt University.
How can I directly contact Steven Ringel?
To contact Steven Ringel directly, you can use the email address *************@tempus.com. Complete contact information is available upon registration with Muraena.
Who is Steven Ringel?
Steven Ringel is a seasoned professional in the commercial physical research industry, currently serving as the General Manager at Tempus, where he leads innovative initiatives in clinical trials. With a strong background in leadership development and consulting, he is passionate about empowering patients with rare diseases through access to experimental therapies. Steven's career spans various roles in biopharma, including significant positions at Sema4, where he advanced healthcare strategies and partnerships. His experience in both corporate and startup environments equips him with a unique perspective on the healthcare landscape. A graduate of Vanderbilt University, Steven combines his expertise in data analysis and public speaking to advocate for change in patient care. He is also fluent in conversational French, enhancing his ability to connect in diverse environments. Steven's commitment to transforming treatment access showcases his dedication to making a meaningful impact in the healthcare sector.
Steven`s contact details
*************@tempus.com
*************@sema4.com
Colleagues
VP, Translational Science
VP Oncology Sales, North America
Area Vice President, Life Sciences
VP of Life Science Revenue Operations
Vice President Clinical Pathology
Chief Accounting Officer (CAO)
Vice President Molecular Assay Development
Vice President of Commercial Markets
Divisional Vice President, Head of Pharma Sequencing and CDx
Chief Privacy Officer